Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 105558
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105558
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105558
Table 2 Comparison of the clinical and laboratory data between the four groups, n (%)
Overall (n = 642) | VitD normal (n = 51) | VitD insufficient (n = 134) | VitD deficient (n = 358) | VitD severely deficient (n = 99) | P value | |
Age (years) | 33.0 (29.0, 36.0) | 33.0 (29.5, 35.5) | 35.0 (31.0, 38.0) | 33.0 (28.0, 36.0) | 31.0 (27.0, 35.0) | < 0.001 |
Female | 228 (35.5) | 31 (60.8) | 33 (24.6) | 118 (33.0) | 46 (46.5) | < 0.001 |
Smoking | 164 (25.5) | 11 (21.6) | 40 (29.9) | 91 (25.4) | 22 (22.2) | 0.511 |
Alcohol | 126 (19.6) | 10 (19.6) | 39 (29.1) | 60 (16.8) | 17 (17.2) | 0.02 |
CVD | 5 (0.8) | 2 (3.9) | 1 (0.7) | 2 (0.6) | 0 (0.0) | 0.057 |
HBP | 109 (17.0) | 4 (7.8) | 22 (16.4) | 67 (18.7) | 16 (16.2) | 0.277 |
Hyperlipemia | 272 (42.4) | 13 (25.5) | 65 (48.5) | 155 (43.3) | 39 (39.4) | 0.037 |
Fatty liver | 389 (60.6) | 17 (33.3) | 83 (61.9) | 225 (62.8) | 64 (64.6) | 0.001 |
Hyperuricemia | 114 (17.8) | 7 (13.7) | 23 (17.2) | 64 (17.9) | 20 (20.2) | 0.799 |
Obesity | 112 (17.4) | 7 (13.7) | 23 (17.2) | 64 (17.9) | 18 (18.2) | 0.901 |
Osteopenia | 17 (2.6) | 2 (3.9) | 3 (2.2) | 12 (3.4) | 0 (0.0) | 0.285 |
CKD | 128 (19.9) | 9 (17.6) | 28 (20.9) | 73 (20.4) | 18 (18.2) | 0.923 |
25VitD, ng/mL | 15.90 (11.77, 21.21) | 35.46 (32.13, 41.36) | 23.51 (21.51, 26.17) | 15.08 (12.71, 17.31) | 7.82 (6.11, 9.05) | < 0.001 |
25VitD2, ng/mL | 0.46 (0.18, 0.84) | 0.53 (0.26, 0.69) | 0.52 (0.21, 0.90) | 0.47 (0.19, 0.90) | 0.33 (0.04, 0.63) | 0.006 |
25VitD3, ng/mL | 15.30 (11.20, 20.40) | 34.20 (31.10, 40.55) | 22.70 (20.90, 25.30) | 14.18 (11.83, 16.50) | 7.29 (5.92, 8.41) | < 0.001 |
LDL-C, mmol/L | 2.88 (2.23, 3.54) | 2.95 (2.42, 3.33) | 2.88 (2.18, 3.53) | 2.87 (2.22, 3.52) | 2.92 (2.37, 3.64) | 0.909 |
HDL-C, mmol/L | 0.94 (0.78, 1.13) | 1.34 (0.90, 1.86) | 0.94 (0.76, 1.14) | 0.93 (0.79, 1.09) | 0.92 (0.79, 1.09) | < 0.001 |
TG, mmol/L | 1.78 (1.18, 2.94) | 2.54 (1.40, 3.23) | 1.97 (1.33, 3.39) | 1.70 (1.15, 2.92) | 1.50 (1.04, 2.33) | 0.007 |
No HDL-C, mmol/L | 3.95 (3.13, 4.84) | 3.95 (3.33, 4.56) | 4.09 (3.42, 4.86) | 3.92 (3.08, 4.86) | 3.86 (3.04, 4.69) | 0.331 |
Apolipoprotein A1, g/L | 1.11 (0.98, 1.28) | 1.58 (1.12, 2.36) | 1.11 (0.98, 1.41) | 1.10 (0.98, 1.24) | 1.08 (0.92, 1.19) | < 0.001 |
Apolipoprotein B, g/L | 0.96 (0.77, 1.18) | 1.00 (0.84, 1.15) | 0.99 (0.82, 1.20) | 0.95 (0.77, 1.18) | 0.90 (0.74, 1.17) | 0.322 |
ApoB/ApoA1 | 0.83 (0.62, 1.06) | 0.61 (0.46, 0.84) | 0.83 (0.61, 1.05) | 0.86 (0.65, 1.08) | 0.82 (0.65, 1.10) | < 0.001 |
Free fatty acids, μmol/L | 530 (398, 694) | 512 (433, 608) | 526 (372, 682) | 525 (393,685) | 571 (411, 758) | 0.302 |
Lipoproteina, mg/L | 108 (47, 203) | 116 (44, 188) | 92 (35, 232) | 117 (47, 201) | 101 (61, 201) | 0.885 |
UA, μmol/L | 369 (291, 439) | 316 (272, 386) | 368 (292, 424) | 373 (295, 440) | 373 (284, 475) | 0.089 |
Glu, mmol/L | 7.08 (5.34, 9.79) | 5.46 (4.40, 7.34) | 6.81 (5.26, 9.34) | 7.32 (5.52, 9.92) | 7.71 (5.66, 10.30) | < 0.001 |
ALB, g/L | 40.0 (37.3, 42.8) | 38.1 (35.1, 41.8) | 40.7 (38.0, 43.8) | 40.1 (37.8, 42.7) | 39.1 (35.7, 42.2) | 0.019 |
ALT, U/L | 30.0 (17.0, 62.0) | 22.0 (11.5, 59.0) | 28.0 (18.0, 60.8) | 31.0 (18.0, 62.0) | 34.0 (16.0, 65.5) | 0.211 |
AST, U/L | 24.0 (16.3, 41.8) | 23.0 (15.0, 33.0) | 23.0 (17.0, 33.8) | 24.0 (17.0, 42.8) | 27.0 (16.0, 46.0) | 0.329 |
ALP, U/L | 79.0 (65.0, 97.0) | 80.0 (65.5, 96.0) | 82.0 (65.0, 101.8) | 78.0 (64.0, 96.0) | 76.0 (64.0, 97.5) | 0.528 |
Scr, μmol/L | 67.1 (55.5, 76.6) | 57.7 (48.1, 70.3) | 70.1 (60.6, 80.0) | 68.1 (56.5, 76.7) | 61.0 (52.0, 73.9) | < 0.001 |
eGFR, mL/minute/1.73 m² | 121.81 (110.17, 132.13) | 125.11 (119.47, 132.95) | 117.11 (108.36, 128.38) | 121.09 (109.86, 132.74) | 124.97 (116.59, 132.42) | 0.015 |
Ca, mmol/L | 2.28 (2.20, 2.36) | 2.29 (2.21, 2.36) | 2.29 (2.22, 2.36) | 2.28 (2.20, 2.36) | 2.27 (2.17, 2.34) | 0.147 |
P, mmol/L | 1.27 (1.14, 1.44) | 1.27 (1.18, 1.44) | 1.28 (1.14, 1.42) | 1.28 (1.15, 1.44) | 1.25 (1.10, 1.44) | 0.613 |
iPTH, pg/mL | 33.1 (24.4, 44.9) | 25.4 (17.4, 31.8) | 30.2 (23.4, 40.6) | 34.5 (26.4, 46.0) | 38.1 (26.7, 46.1) | < 0.001 |
Hemoglobin, g/L | 147 (131, 159) | 132 (119, 152) | 151 (139, 160) | 148 (133, 160) | 144 (130, 156) | 0.001 |
White blood cell, × 109/L | 7.23 (6.09, 8.71) | 8.54 (6.43, 9.68) | 7.00 (6.09, 8.46) | 7.14 (6.02, 8.48) | 7.99 (6.30, 9.04) | 0.004 |
PLT, × 109/L | 237 (196, 280) | 224 (192, 258) | 233 (192, 277) | 237 (198, 276) | 256 (207, 318) | 0.011 |
- Citation: Hu Y, Shao LN, Zheng J, Zhang XM, Song YX, Xing YB. Vitamin D deficiency is associated with apolipoprotein A1 levels in patients with young-onset type 2 diabetes mellitus. World J Diabetes 2025; 16(6): 105558
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/105558.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.105558